カテゴリー： QYResearch, 世界

世界の全身性特発性若年性関節炎の治療市場 2019年

【英語タイトル】Global Systemic Idiopathic Juvenile Arthritis Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16229）・商品コード：DATA909X16229
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、全身性特発性若年性関節炎の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他に、用途別には、クリニック、病院、その他にセグメント区分し、全身性特発性若年性関節炎の治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・全身性特発性若年性関節炎の治療の世界市場概要
・全身性特発性若年性関節炎の治療の製造コスト構成分析
・全身性特発性若年性関節炎の治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・全身性特発性若年性関節炎の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・全身性特発性若年性関節炎の治療のセグメント分析（種類別）
（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）
・全身性特発性若年性関節炎の治療のセグメント分析（用途別）
（クリニック、病院、その他）
・全身性特発性若年性関節炎の治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Alteogen Inc.、Bristol-Myers Squibb Company、Epirus Biopharmaceuticals, Inc.、Johnson & Johnson、Momenta Pharmaceuticals, Inc.、Mycenax Biotech Inc.、Novartis AG、Oncobiologics, Inc.、）
・全身性特発性若年性関節炎の治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Systemic Idiopathic Juvenile Arthritis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Idiopathic Juvenile Arthritis Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Systemic Idiopathic Juvenile Arthritis Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Systemic Idiopathic Juvenile Arthritis Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alteogen Inc.
Bristol-Myers Squibb Company
Epirus Biopharmaceuticals, Inc.
Johnson & Johnson
Momenta Pharmaceuticals, Inc.
Mycenax Biotech Inc.
Novartis AG
Oncobiologics, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Adalimumab Biosimilar
Canakinumab
Golimumab
Tocilizumab Biosimilar
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Systemic Idiopathic Juvenile Arthritis Treatment
1.1 Definition of Systemic Idiopathic Juvenile Arthritis Treatment
1.2 Systemic Idiopathic Juvenile Arthritis Treatment Segment by Type
1.2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Adalimumab Biosimilar
1.2.3 Canakinumab
1.2.4 Golimumab
1.2.5 Tocilizumab Biosimilar
1.2.6 Others
1.3 Systemic Idiopathic Juvenile Arthritis Treatment Segment by Applications
1.3.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Overall Market
1.4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue (2014-2025)
1.4.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Production (2014-2025)
1.4.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)
1.4.4 Europe Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)
1.4.5 China Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)
1.4.6 Japan Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)
1.4.8 India Systemic Idiopathic Juvenile Arthritis Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Systemic Idiopathic Juvenile Arthritis Treatment
2.3 Manufacturing Process Analysis of Systemic Idiopathic Juvenile Arthritis Treatment
2.4 Industry Chain Structure of Systemic Idiopathic Juvenile Arthritis Treatment

3 Development and Manufacturing Plants Analysis of Systemic Idiopathic Juvenile Arthritis Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Systemic Idiopathic Juvenile Arthritis Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Systemic Idiopathic Juvenile Arthritis Treatment Production and Capacity Analysis
4.2 Systemic Idiopathic Juvenile Arthritis Treatment Revenue Analysis
4.3 Systemic Idiopathic Juvenile Arthritis Treatment Price Analysis
4.4 Market Concentration Degree

5 Systemic Idiopathic Juvenile Arthritis Treatment Regional Market Analysis
5.1 Systemic Idiopathic Juvenile Arthritis Treatment Production by Regions
5.1.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Production by Regions
5.1.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Regions
5.2 Systemic Idiopathic Juvenile Arthritis Treatment Consumption by Regions
5.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.3.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Production
5.3.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Systemic Idiopathic Juvenile Arthritis Treatment Import and Export
5.4 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.4.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Production
5.4.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Systemic Idiopathic Juvenile Arthritis Treatment Import and Export
5.5 China Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.5.1 China Systemic Idiopathic Juvenile Arthritis Treatment Production
5.5.2 China Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Systemic Idiopathic Juvenile Arthritis Treatment Import and Export
5.6 Japan Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.6.1 Japan Systemic Idiopathic Juvenile Arthritis Treatment Production
5.6.2 Japan Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Systemic Idiopathic Juvenile Arthritis Treatment Import and Export
5.7 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.7.1 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production
5.7.2 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Import and Export
5.8 India Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis
5.8.1 India Systemic Idiopathic Juvenile Arthritis Treatment Production
5.8.2 India Systemic Idiopathic Juvenile Arthritis Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Systemic Idiopathic Juvenile Arthritis Treatment Import and Export

6 Systemic Idiopathic Juvenile Arthritis Treatment Segment Market Analysis (by Type)
6.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Production by Type
6.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Type
6.3 Systemic Idiopathic Juvenile Arthritis Treatment Price by Type

7 Systemic Idiopathic Juvenile Arthritis Treatment Segment Market Analysis (by Application)
7.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption by Application
7.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Market Share by Application (2014-2019)

8 Systemic Idiopathic Juvenile Arthritis Treatment Major Manufacturers Analysis
8.1 Alteogen Inc.
8.1.1 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.1.2 Alteogen Inc. Product Introduction, Application and Specification
8.1.3 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Epirus Biopharmaceuticals, Inc.
8.3.1 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.3.2 Epirus Biopharmaceuticals, Inc. Product Introduction, Application and Specification
8.3.3 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.4.2 Johnson & Johnson Product Introduction, Application and Specification
8.4.3 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Momenta Pharmaceuticals, Inc.
8.5.1 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.5.2 Momenta Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.5.3 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mycenax Biotech Inc.
8.6.1 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.6.2 Mycenax Biotech Inc. Product Introduction, Application and Specification
8.6.3 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis AG
8.7.1 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.7.2 Novartis AG Product Introduction, Application and Specification
8.7.3 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Oncobiologics, Inc.
8.8.1 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
8.8.2 Oncobiologics, Inc. Product Introduction, Application and Specification
8.8.3 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Systemic Idiopathic Juvenile Arthritis Treatment Market
9.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Trend Analysis
9.1.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Systemic Idiopathic Juvenile Arthritis Treatment Regional Market Trend
9.2.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.2.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.2.3 China Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.2.4 Japan Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.2.5 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.2.6 India Systemic Idiopathic Juvenile Arthritis Treatment Forecast 2019-2025
9.3 Systemic Idiopathic Juvenile Arthritis Treatment Market Trend (Product Type)
9.4 Systemic Idiopathic Juvenile Arthritis Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Systemic Idiopathic Juvenile Arthritis Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Systemic Idiopathic Juvenile Arthritis Treatment
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share by Types in 2018
Figure Adalimumab Biosimilar Product Picture
Figure Canakinumab Product Picture
Figure Golimumab Product Picture
Figure Tocilizumab Biosimilar Product Picture
Figure Others Product Picture
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue (Million USD) (2014-2025)
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs) (2014-2025)
Figure North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Figure Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Figure China Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Figure Japan Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Figure India Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Million USD) (2014-2025)
Table Systemic Idiopathic Juvenile Arthritis Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Systemic Idiopathic Juvenile Arthritis Treatment in 2018
Figure Manufacturing Process Analysis of Systemic Idiopathic Juvenile Arthritis Treatment
Figure Industry Chain Structure of Systemic Idiopathic Juvenile Arthritis Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Manufacturing Plants Distribution
Table Systemic Idiopathic Juvenile Arthritis Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Systemic Idiopathic Juvenile Arthritis Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Systemic Idiopathic Juvenile Arthritis Treatment Production Share by Manufacturers in 2018
Table Systemic Idiopathic Juvenile Arthritis Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Systemic Idiopathic Juvenile Arthritis Treatment Revenue Share by Manufacturers in 2018
Table Systemic Idiopathic Juvenile Arthritis Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share by Regions 2014-2019
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share by Regions in 2018
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Regions 2014-2019
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Regions in 2018
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Market Share by Regions 2014-2019
Figure North America Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure China Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure India Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2014-2019)
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Sites and Area Served
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product Introduction, Application and Specification
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate (2014-2019)
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share (2014-2019)
Figure Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share (2014-2019)
Table Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Main Business and Markets Served
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Systemic Idiopathic Juvenile Arthritis Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Systemic Idiopathic Juvenile Arthritis Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Systemic Idiopathic Juvenile Arthritis Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Systemic Idiopathic Juvenile Arthritis Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Systemic Idiopathic Juvenile Arthritis Treatment by Application (2019-2025)
Table Systemic Idiopathic Juvenile Arthritis Treatment Distributors List
Table Systemic Idiopathic Juvenile Arthritis Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Alteogen Inc.、Bristol-Myers Squibb Company、Epirus Biopharmaceuticals, Inc.、Johnson & Johnson、Momenta Pharmaceuticals, Inc.、Mycenax Biotech Inc.、Novartis AG、Oncobiologics, Inc.、

★調査レポート[世界の全身性特発性若年性関節炎の治療市場 2019年] (コード：DATA909X16229)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全身性特発性若年性関節炎の治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の多関節若年性特発性関節炎治療薬市場 2019年
    DATA909X13266 / QYResearch / 2019年11月20日 / ※本調査レポートは、多関節若年性特発性関節炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他に、用途別には、病院、診療所、その他にセグメント区分し、多関節若年性特発性関節炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多関節若年性特発性関節炎治療薬の世界市場概要 ・多関節若年性特発性関節炎治療薬の製造コスト構成分析 ・多関節若年性特発性関節炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多関節若年性特発性関節炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多関節若年性特発性関節炎治療薬のセグメント分析（種類別） （エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）...The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polyarticular Juvenile Idiopathic Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polyarticular Juvenile Idiopathic Arthritis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polyarticular Juvenile Idiopathic Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の若年性黄斑変性症治療市場 2019年
    DATA909X10164 / QYResearch / 2019年11月20日 / ※本調査レポートは、若年性黄斑変性症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、若年性黄斑変性症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・若年性黄斑変性症治療の世界市場概要 ・若年性黄斑変性症治療の製造コスト構成分析 ・若年性黄斑変性症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・若年性黄斑変性症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・若年性黄斑変性症治療のセグメント分析（種類別） （アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）...The global Juvenile Macular Degeneration Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Juvenile Macular Degeneration Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Juvenile Macular Degeneration Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Juvenile Macular Degeneration Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 特発性肺線維症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18557 / QYResearch / 2019年11月25日 / ※当調査レポートでは、特発性肺線維症治療の世界市場について調査・分析し、特発性肺線維症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、酸素療法、肺移植、その他）、用途別（病院、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の特発性肺線維症治療市場動向 ・主要企業別マーケットシェア ・特発性肺線維症治療の種類別市場規模2014-2019 （薬物クラス、酸素療法、肺移植、その他） ・特発性肺線維症治療の用途別市場規模2014-2019 （病院、クリニック） ・特発性肺線維症治療の北米市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. In 2018, the global Idiopathic Pulmonary Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Idiopathic Pulmonary Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Idiopathic Pulmonary Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South...
  • 乾癬性関節炎（PsA）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103337 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、乾癬性関節炎（PsA）治療の世界市場について調べ、まとめました。種類別セグメントは、非ステロイド系抗炎症薬、疾患修飾性抗リウマチ薬、生物製剤等、用途別セグメントは、病院、診療所、その他等に区分しました。乾癬性関節炎（PsA）治療の世界市場概観、企業動向、企業別乾癬性関節炎（PsA）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乾癬性関節炎（PsA）治療の市場概観 ・乾癬性関節炎（PsA）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乾癬性関節炎（PsA）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・乾癬性関節炎（PsA）治療の世界市場規模 ・乾癬性関節炎（PsA）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・乾癬性関節炎（PsA）治療のアメリカ市場規模推移 ・乾癬性関節炎（PsA）治療のカナダ市場規模推移 ・乾癬性関節炎（PsA）治療のメキシコ市場規模推移 ・乾癬性関節炎（PsA）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Psoriatic Arthritis (PsA) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriatic Arthritis (PsA) Treatment. Europe also play important...

    • ◆H&Iグローバルリサーチのお客様（例）◆